{
    "title": "114_hr2391",
    "content": "The Act titled \"Medicaid Generic Drug Price Fairness Act of 2015\" applies the Medicaid additional rebate requirement to generic drugs. The Medicaid Generic Drug Price Fairness Act of 2015 amends Section 1927(c)(3) of the Social Security Act to include an additional rebate requirement for generic drugs. The Medicaid Generic Drug Price Fairness Act of 2015 adds a rebate requirement for generic drugs, increasing rebates for different drug forms and strengths in a similar manner to single source or innovator drugs. The Medicaid Generic Drug Price Fairness Act of 2015 increases rebates for generic drugs, aligning their strength with single source or innovator drugs. The reference to '1990' in subparagraph (A)(i) is changed to '2014' under special rules. The Medicaid Generic Drug Price Fairness Act of 2015 adjusts references to '1990' to '2014' and updates the calendar quarter for average manufacturer price calculations. The Medicaid Generic Drug Price Fairness Act of 2015 updates references to '1990' to '2014' and changes the calendar quarter for average manufacturer price calculations to the lowest quarter ending on September 30, 2014. The Medicaid Generic Drug Price Fairness Act of 2015 updates references to '1990' to '2014' and changes the calendar quarter for average manufacturer price calculations to the lowest quarter ending on September 30, 2014. In subparagraph (A)(ii), the reference to 'September 1990' is now 'the last month of such calendar quarter'. References in subparagraph (D) to 'paragraph (1)(A)(ii)', 'this paragraph', and 'December 31, 2009' are now updated. The Medicaid Generic Drug Price Fairness Act of 2015 updates references to '1990' to '2014' and changes the calendar quarter for average manufacturer price calculations to the lowest quarter ending on September 30, 2014. In subparagraph (D), references to 'paragraph (1)(A)(ii)', 'this paragraph', and 'December 31, 2009' are now updated to 'subparagraph (A)', 'this subparagraph', and 'December 31, 2014', respectively. Any mention of a 'single source drug or an innovator multiple source drug' is now referred to as a single source drug. The Medicaid Generic Drug Price Fairness Act of 2015 updates references to '1990' to '2014' and changes the average manufacturer price calculations to the lowest quarter ending on September 30, 2014. Mentions of 'single source drug or an innovator multiple source drug' are now referred to as a single source drug. The Medicaid Generic Drug Price Fairness Act of 2015 updates references to '1990' to '2014' and changes the average manufacturer price calculations to the lowest quarter ending on September 30, 2014. When applying paragraph (2)(A)(ii)(II) to a covered outpatient drug first sold after 3 years before the enactment date, 'the applicable quarter' is substituted for 'the calendar quarter beginning July 1, 1990'. The Medicaid Generic Drug Price Fairness Act of 2015 updates references to '1990' to '2014' and changes the average manufacturer price calculations to the lowest quarter ending on September 30, 2014. When applying paragraph (2)(A)(ii)(II) to a covered outpatient drug first sold after 3 years before the enactment date, 'the applicable quarter' is substituted for 'the calendar quarter beginning July 1, 1990'. In this subsection, the term 'applicable quarter' means the fifth full calendar quarter. The Medicaid Generic Drug Price Fairness Act of 2015 updates references to '1990' to '2014' and changes the average manufacturer price calculations to the lowest quarter ending on September 30, 2014. The term 'applicable quarter' in this subsection refers to the fifth full calendar quarter for drugs not classified as single source or innovator multiple source. The amendments apply to rebate periods starting after December 31, 2014."
}